IsofraxidinCAS# 486-21-5 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 486-21-5 | SDF | Download SDF |
PubChem ID | 5318565 | Appearance | White-pale yellow powder |
Formula | C11H10O5 | M.Wt | 222.19 |
Type of Compound | Coumarins | Storage | Desiccate at -20°C |
Synonyms | 6,8-Dimethoxyumbelliferone; 7-Hydroxy 6,8-dimethoxycoumarin | ||
Solubility | DMSO : 250 mg/mL (1125.16 mM; Need ultrasonic) | ||
Chemical Name | 7-hydroxy-6,8-dimethoxychromen-2-one | ||
SMILES | COC1=C(C(=C2C(=C1)C=CC(=O)O2)OC)O | ||
Standard InChIKey | HOEVRHHMDJKUMZ-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C11H10O5/c1-14-7-5-6-3-4-8(12)16-10(6)11(15-2)9(7)13/h3-5,13H,1-2H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Isofraxidin has definite anti-bacterial, anti-oxidant, analgesic,and anti-inflammatory activities, it inhibits expression of MMP-7 and in vitro cell invasion at a non-toxic level through inhibiting ERK1/2 phosphorylation in hepatoma cell lines.Isofraxidin is one possible radio-protector, it can protect leukemia cells from radiation-induced apoptosis via ROS/mitochondria pathway in a p53-independent manner. |
Targets | ROS | p53 | COX | PGE | TNF-α | p38MAPK | ERK | MMP(e.g.TIMP) | JNK | NF-kB | NO | IL Receptor | Caspase | Bcl-2/Bax | Calcium Channel | ERK | AP-1 |
In vitro | Isofraxidin, a coumarin component from Acanthopanax senticosus, inhibits matrix metalloproteinase-7 expression and cell invasion of human hepatoma cells.[Pubmed: 20930381]Biol Pharm Bull. 2010;33(10):1716-22.7-Hydroxy-6,8-dimethoxy-2H-1-benzopyran-2-one (Isofraxidin) is a major coumarin component isolated from the stem bark of Acanthopanax senticosus, a widely used Chinese medicinal herb.
|
In vivo | Isofraxidin protects mice from LPS challenge by inhibiting pro-inflammatory cytokines and alleviating histopathological changes.[Pubmed: 25454811]Immunobiology. 2015 Mar;220(3):406-13.Isofraxidin (IF), the major bioactive component of Sarcandra glabra, has been reported to be an effective anti-inflammatory compound.
Isofraxidin exhibited anti-inflammatory effects in vivo and inhibited TNF-α production in LPS-induced mouse peritoneal macrophages in vitro via the MAPK pathway.[Pubmed: 22800929]Int Immunopharmacol. 2012 Oct;14(2):164-71.Isofraxidin (IF) is a Coumarin compound that can be isolated from medicinal plants, such as Sarcandra glabra (Thunb.). Nakai is widely used in Asian countries for the treatment of anti-bacterial, anti-inflammatory and anti-tumour action.
|
Animal Research | Protective effects of Isofraxidin against lipopolysaccharide-induced acute lung injury in mice.[Pubmed: 25596039]Int Immunopharmacol. 2015 Feb;24(2):432-9.Acute lung injury (ALI) is a life-threatening disease characterized by serious lung inflammation and increased capillary permeability, which presents a high mortality worldwide. Isofraxidin (IF), a Coumarin compound isolated from the natural medicinal plants such as Sarcandra glabra and Acanthopanax senticosus, has been reported to have definite anti-bacterial, anti-oxidant, and anti-inflammatory activities. However, the effects of Isofraxidin against lipopolysaccharide-induced ALI have not been clarified. The aim of the present study is to explore the protective effects and potential mechanism of Isofraxidin against LPS-induced ALI in mice.
|
Isofraxidin Dilution Calculator
Isofraxidin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.5007 mL | 22.5033 mL | 45.0065 mL | 90.0131 mL | 112.5163 mL |
5 mM | 0.9001 mL | 4.5007 mL | 9.0013 mL | 18.0026 mL | 22.5033 mL |
10 mM | 0.4501 mL | 2.2503 mL | 4.5007 mL | 9.0013 mL | 11.2516 mL |
50 mM | 0.09 mL | 0.4501 mL | 0.9001 mL | 1.8003 mL | 2.2503 mL |
100 mM | 0.045 mL | 0.225 mL | 0.4501 mL | 0.9001 mL | 1.1252 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- PMX 464
Catalog No.:BCC6348
CAS No.:485842-97-5
- Mirabijalone D
Catalog No.:BCN4071
CAS No.:485811-84-5
- Choline sulphate
Catalog No.:BCN1792
CAS No.:4858-96-2
- Proanthocyanidins
Catalog No.:BCN6313
CAS No.:4852-22-6
- 5,7,3'-Trihydroxyflavanone
Catalog No.:BCC8269
CAS No.:104732-07-2
- Hydrangetin
Catalog No.:BCN7439
CAS No.:485-90-5
- Formononetin
Catalog No.:BCN1061
CAS No.:485-72-3
- Cinchonidine
Catalog No.:BCC5316
CAS No.:485-71-2
- (+)-Bicuculline
Catalog No.:BCN1238
CAS No.:485-49-4
- Cytisine
Catalog No.:BCN6270
CAS No.:485-35-8
- Reticuline
Catalog No.:BCN5583
CAS No.:485-19-8
- Aristolochic acid C
Catalog No.:BCN2658
CAS No.:4849-90-5
- Fraxinol
Catalog No.:BCN5584
CAS No.:486-28-2
- Daphnetin
Catalog No.:BCN1051
CAS No.:486-35-1
- (S)-Coclaurine
Catalog No.:BCN5585
CAS No.:486-39-5
- (-)-Cotinine
Catalog No.:BCC7569
CAS No.:486-56-6
- Bergaptol
Catalog No.:BCN5588
CAS No.:486-60-2
- Ononin
Catalog No.:BCN5926
CAS No.:486-62-4
- Isoformononetin
Catalog No.:BCN8206
CAS No.:486-63-5
- Vasicinone
Catalog No.:BCN5589
CAS No.:486-64-6
- Daidzein
Catalog No.:BCN5590
CAS No.:486-66-8
- Harman
Catalog No.:BCN3998
CAS No.:486-84-0
- N-Methylcytisine
Catalog No.:BCN1266
CAS No.:486-86-2
- alpha-Isolupanine
Catalog No.:BCN7989
CAS No.:486-87-3
Protective effects of Isofraxidin against lipopolysaccharide-induced acute lung injury in mice.[Pubmed:25596039]
Int Immunopharmacol. 2015 Feb;24(2):432-439.
Acute lung injury (ALI) is a life-threatening disease characterized by serious lung inflammation and increased capillary permeability, which presents a high mortality worldwide. Isofraxidin (IF), a Coumarin compound isolated from the natural medicinal plants such as Sarcandra glabra and Acanthopanax senticosus, has been reported to have definite anti-bacterial, anti-oxidant, and anti-inflammatory activities. However, the effects of IF against lipopolysaccharide-induced ALI have not been clarified. The aim of the present study is to explore the protective effects and potential mechanism of IF against LPS-induced ALI in mice. In this study, We found that pretreatment with IF significantly lowered LPS-induced mortality and lung wet-to-dry weight (W/D) ratio and reduced the levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and prostaglandin E2 (PGE2) in serum and bronchoalveolar lavage fluid (BALF). We also found that total cells, neutrophils and macrophages in BALF, MPO activity in lung tissues were markedly decreased. Besides, IF obviously inhibited lung histopathological changes and cyclooxygenase-2 (COX-2) protein expression. These results suggest that IF has a protective effect against LPS-induced ALI, and the protective effect of IF seems to result from the inhibition of COX-2 protein expression in the lung, which regulates the production of PGE2.
Isofraxidin, a coumarin component from Acanthopanax senticosus, inhibits matrix metalloproteinase-7 expression and cell invasion of human hepatoma cells.[Pubmed:20930381]
Biol Pharm Bull. 2010;33(10):1716-22.
7-Hydroxy-6,8-dimethoxy-2H-1-benzopyran-2-one (Isofraxidin) is a major coumarin component isolated from the stem bark of Acanthopanax senticosus, a widely used Chinese medicinal herb. We investigated Isofraxidin in its anti-tumor effects on human hepatoma cell lines HuH-7 and HepG2. Isofraxidin significantly inhibited hepatoma cell invasion, without affecting cell attachment or growth. Expression of 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced matrix metalloproteinase-7 (MMP-7) in hepatoma cells was inhibited by Isofraxidin at the both mRNA and protein levels. This inhibition tended to be greater in cells inoculated at low density than in those at high density. Isofraxidin showed an inhibitory effect on the phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2) in hepatoma cells, whereas activator protein-1 (AP-1) DNA binding activity, nuclear factor-kappa B (NF-kappaB) nuclear translocation, and inhibitory kappa B (IkappaB) degradation were affected very little. These results indicate that Isofraxidin inhibits expression of MMP-7 and in vitro cell invasion at a non-toxic level through inhibiting ERK1/2 phosphorylation in hepatoma cell lines, which suggest Isofraxidin might become an effective agent for suppressing hepatoma cell invasion.
Isofraxidin exhibited anti-inflammatory effects in vivo and inhibited TNF-alpha production in LPS-induced mouse peritoneal macrophages in vitro via the MAPK pathway.[Pubmed:22800929]
Int Immunopharmacol. 2012 Oct;14(2):164-71.
Isofraxidin (IF) is a Coumarin compound that can be isolated from medicinal plants, such as Sarcandra glabra (Thunb.). Nakai is widely used in Asian countries for the treatment of anti-bacterial, anti-inflammatory and anti-tumour action. The present investigation was designed to evaluate the effect of IF on inflammation and nociception. In addition, we investigated a potential novel mechanism to explain the anti-inflammatory properties of IF. In vivo, xylene-induced mouse ear edema, carrageenan-induced rat paw edema, LPS-induced mouse endotoxic shock, acetic acid-induced mice writhing and formalin-induced mouse pain models were used to evaluate the anti-inflammatory activity of IF. In vitro, we examined the effects of IF inhibition on TNF-alpha production and the regulation of ERK1/2 and p38 phosphorylation activity in LPS-induced mouse peritoneal macrophages. Our results demonstrated that IF can significantly decrease xylene-induced ear edema, carrageenan-induced paw edema, acetic acid-induced writhing and formalin-induced pain. Moreover, IF greatly inhibited the production of TNF-alpha in the serum of LPS-stimulated mice and peritoneal macrophages, and it decreased phospho-p38 and ERK1/2 protein expression in LPS-stimulated mouse peritoneal macrophages. Overall, our data suggest that IF possesses significant analgesic and anti-inflammatory activities that may be mediated through the regulation of pro-inflammatory cytokines, TNF-alpha and the phosphorylation of p38 and ERK1/2.
Isofraxidin, a potent reactive oxygen species (ROS) scavenger, protects human leukemia cells from radiation-induced apoptosis via ROS/mitochondria pathway in p53-independent manner.[Pubmed:24692054]
Apoptosis. 2014 Jun;19(6):1043-53.
Ionizing radiation (IR) leads to oxidizing events such as excessive reactive oxygen species (ROS) in the exposed cells, resulting in further oxidative damage to lipids, proteins and DNA. To screen the potential radio-protective drug, the intracellular ROS was measured in irradiated U937 cells pretreated with 80 candidate traditional herbal medicine, respectively. Isofraxidin (IF) was one possible radio-protector in these 80 drugs. This study investigated the radio-protective role of IF, a Coumarin compound, in human leukemia cell lines, for the first time. Results indicate that IF protects against IR-induced apoptosis in U937 cells in the time- and concentration- dependent manner. IF decreases IR-induced intracellular ROS generation, especially hydroxyl radicals formation, inhibits IR-induced mitochondrial membrane potential loss and reduces IR-induced high intracellular Ca(2+) levels regardless of ER stress. IF down-regulates the expression of caspase-3, phospho-JNK, phospho-p38 and activates Bax in mitochondria. IF inhibits cytochrome c release from mitochondria to cytosol. IF also moderates IR-induced Fas externalization and caspase-8 activation. IF also exhibits significant protection against IR-induced cell death in other leukemia cell lines such as Molt-4 cells and HL60 cells regardless of p53. Taken together, the data demonstrate that IF protects leukemia cells from radiation-induced apoptosis via ROS/mitochondria pathway in a p53-independent manner.
Isofraxidin protects mice from LPS challenge by inhibiting pro-inflammatory cytokines and alleviating histopathological changes.[Pubmed:25454811]
Immunobiology. 2015 Mar;220(3):406-13.
Isofraxidin (IF), the major bioactive component of Sarcandra glabra, has been reported to be an effective anti-inflammatory compound. In a previous study, we showed that IF acts via the MAPK pathway to produce anti-inflammatory effects, both in vivo and in vitro. However, the effect and mechanism of action of IF on inflammatory cytokines and NF-kappaB activation in vivo has not been investigated. We therefore aimed to evaluate how IF regulates the production of inflammatory cytokines in vivo by intraperitoneal injection of IF (1, 5 or 15mg/kg) prior to treatment with LPS (1mg/kg, i.p.). Macroscopic, biochemical and histopathological parameters were measured. Treatment with IF prior to LPS challenge decreased mortality rate, body weight loss, organ coefficient and histopathological changes. IF also suppressed the protein expression of NF-kappaB, levels of NO and IL-6 in serum and production of TNF-alpha in liver. Our results show that pretreatment with IF increases the survival rate following LPS stimulation in mice. The effect involves regulation of NF-kappaB signal which, in turn, regulates production of inflammatory cytokine TNF-alpha, suggesting that IF may have a therapeutic effect against LPS-induced inflammatory disease.